PDCD1LG2 and head and neck squamous cell carcinoma: PD-L2 is expressed in both the TC and stroma of HNSCC (66), and in a cohort of operable HNSCC patients, 62.7% of HNSCC tumors show positive staining of PD-L2, revealing PD-L2 an independent predictor of shorter OS (67).